MedTrace Logo

Endoscopic Vacuum Therapy for Transmural Defects in the Upper Gastrointestinal Tract

NCT05606822 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-07-23

No results posted yet for this study

Summary

The goal of this observational study is to learn about the best indications and techniques regarding endoscopic vacuum therapy (EVT) in patients with a transmural defect in the upper gastrointestinal (GI) tract (e.g. anastomotic leakage, Boerhaave syndrome, iatrogenic perforation, other). The main questions it aims to answer are:

* What is the success rate of EVT for transmural defects in the upper GI tract?
* What are the best indications for EVT in the upper GI tract? (e.g. etiology, patient characteristics, defect characteristics)
* What are the best techniques for EVT in the upper GI tract? (e.g. EsoSponge, VACStent, vacuum pressure, intraluminal/intracavitary) Participants will be asked for informed consent to retrospectively and prospectively collect data on EVT.

Conditions

  • Endoscopic Vacuum Therapy
  • Anastomotic Leak
  • Esophageal Perforation
  • Esophageal Perforation, Traumatic
  • EsoSponge
  • VACStent

Interventions

OTHER

Observational

Collection of data from electronic health record

Sponsors & Collaborators

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    lead OTHER

Principal Investigators

  • Roos Pouw, MD, PhD · Amsterdam University Medical Center, location VU

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2030-10-01
Completion
2030-10-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05606822 on ClinicalTrials.gov